Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Tanabe

Showing results (151-160 of 272) with videos related to

Pageof 28
Sort By:
Scientific Reports|June 9, 2023
Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinomaKohei Yagi, Shu Shimada, Yoshimitsu Akiyama, et al.
Updates in Surgery|July 11, 2015
The difficulty of laparoscopic liver resectionDaisuke Ban, Atsushi Kudo, Hiromitsu Ito, et al.
Annals of Surgical Oncology|October 8, 2014
Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolboxShigenori Ei, Taizo Hibi, Minoru Tanabe, et al.
Plos One|April 12, 2021
Prediction of early recurrence of pancreatic ductal adenocarcinoma after resectionToshitaka Sugawara, Daisuke Ban, Jo Nishino, et al.
Surgery Today|December 9, 2024
Middle segment preserving pancreatectomy versus total pancreatectomy: a comparative analysis of short- and long-term outcomesMasahiro Yamane, Yoshiya Ishikawa, Hironari Yamashita, et al.
Iscience|February 7, 2022
Immune subtypes and neoantigen-related immune evasion in advanced colorectal cancerToshitaka Sugawara, Fuyuki Miya, Toshiaki Ishikawa, et al.
Transplantation|March 7, 2008
Neutralization of blood group A-antigen by a novel anti-A antibody: overcoming ABO-incompatible solid-organ transplantationYasushi Hasegawa, Yukinari Kato, Mika Kato Kaneko, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|December 15, 2021
Safety and response after peptide receptor radionuclide therapy with <sup>177</sup> Lu-DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trialAtsushi Kudo, Ukihide Tateishi, Ryoichi Yoshimura, et al.
Cancer Science|December 4, 2020
Intestinal phenotype is maintained by Atoh1 in the cancer region of intraductal papillary mucinous neoplasmNobuhiro Katsukura, Sho Watanabe, Tomoaki Shirasaki, et al.
Journal of Gastroenterology|January 8, 2016
Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factorsKeiichi Akahoshi, Shinji Tanaka, Kaoru Mogushi, et al.
Pageof 28

Showing results (151-160 of 272) with videos related to

Sort By:
Pageof 28
Scientific Reports|June 9, 2023
Loss of SFXN1 mitigates lipotoxicity and predicts poor outcome in non-viral hepatocellular carcinomaKohei Yagi, Shu Shimada, Yoshimitsu Akiyama, et al.
Updates in Surgery|July 11, 2015
The difficulty of laparoscopic liver resectionDaisuke Ban, Atsushi Kudo, Hiromitsu Ito, et al.
Annals of Surgical Oncology|October 8, 2014
Cryoablation provides superior local control of primary hepatocellular carcinomas of >2 cm compared with radiofrequency ablation and microwave coagulation therapy: an underestimated tool in the toolboxShigenori Ei, Taizo Hibi, Minoru Tanabe, et al.
Plos One|April 12, 2021
Prediction of early recurrence of pancreatic ductal adenocarcinoma after resectionToshitaka Sugawara, Daisuke Ban, Jo Nishino, et al.
Surgery Today|December 9, 2024
Middle segment preserving pancreatectomy versus total pancreatectomy: a comparative analysis of short- and long-term outcomesMasahiro Yamane, Yoshiya Ishikawa, Hironari Yamashita, et al.
Iscience|February 7, 2022
Immune subtypes and neoantigen-related immune evasion in advanced colorectal cancerToshitaka Sugawara, Fuyuki Miya, Toshiaki Ishikawa, et al.
Transplantation|March 7, 2008
Neutralization of blood group A-antigen by a novel anti-A antibody: overcoming ABO-incompatible solid-organ transplantationYasushi Hasegawa, Yukinari Kato, Mika Kato Kaneko, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|December 15, 2021
Safety and response after peptide receptor radionuclide therapy with <sup>177</sup> Lu-DOTATATE for neuroendocrine tumors in phase 1/2 prospective Japanese trialAtsushi Kudo, Ukihide Tateishi, Ryoichi Yoshimura, et al.
Cancer Science|December 4, 2020
Intestinal phenotype is maintained by Atoh1 in the cancer region of intraductal papillary mucinous neoplasmNobuhiro Katsukura, Sho Watanabe, Tomoaki Shirasaki, et al.
Journal of Gastroenterology|January 8, 2016
Expression of connective tissue growth factor in the livers of non-viral hepatocellular carcinoma patients with metabolic risk factorsKeiichi Akahoshi, Shinji Tanaka, Kaoru Mogushi, et al.
Pageof 28